Crinetics Pharmaceuticals (CRNX) Operating Margin: 2017-2025
Historic Operating Margin for Crinetics Pharmaceuticals (CRNX) over the last 6 years, with Sep 2025 value amounting to -99,710.49%.
- Crinetics Pharmaceuticals' Operating Margin was N/A to -99,710.49% in Q3 2025 from the same period last year, while for Sep 2025 it was -24,707.76%, marking a year-over-year change of. This contributed to the annual value of -32,613.47% for FY2024, which is 2706630.00% down from last year.
- According to the latest figures from Q3 2025, Crinetics Pharmaceuticals' Operating Margin is -99,710.49%, which was down 696.22% from -12,522.99% recorded in Q2 2025.
- Over the past 5 years, Crinetics Pharmaceuticals' Operating Margin peaked at -1,080.39% during Q1 2022, and registered a low of -99,710.49% during Q3 2025.
- Moreover, its 3-year median value for Operating Margin was -14,784.18% (2023), whereas its average is -24,941.28%.
- Examining YoY changes over the last 5 years, Crinetics Pharmaceuticals' Operating Margin showed a top increase of 822,463bps in 2025 and a maximum decrease of 1,937,120bps in 2025.
- Over the past 4 years, Crinetics Pharmaceuticals' Operating Margin (Quarterly) stood at -6,707.48% in 2022, then tumbled by 755,760bps to -17,045.38% in 2023, then slumped by 1,538,375bps to -20,747.62% in 2024, then soared by 822,463bps to -99,710.49% in 2025.
- Its Operating Margin stands at -99,710.49% for Q3 2025, versus -12,522.99% for Q2 2025 and -30,860.11% for Q1 2025.